POCI
Precision Optics Corporation, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$4.38
+0.23%Year over year
Reported trailing growth
- Revenue
- +64.2%
- EBITDA
- +15.8%
- EBIT
- +14.3%
- EPS
- +25.4%
- Free cash flow
- +54.8%
- Operating cash flow
- +62.8%
Forward estimates
Based on analyst estimates
- Revenue
- +18.9%
- EBITDA
- +99.5%
- EPS
- +89.5%
Three-year CAGR
- Revenue
- +6.8%
- EBITDA
- —
- EBIT
- —
- Net income
- -95.8%
- EPS
- -73.5%
- Free cash flow
- -26.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026